• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Argos Therapeutics, Inc. (ARGS)

    -NasdaqGM
    6.16 Up 0.01(0.16%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.15
    Open:6.10
    Bid:5.55 x 2200
    Ask:8.00 x 1000
    1y Target Est:17.40
    Beta:N/A
    Earnings Date:Nov 11 - Nov 16 (Est.)
    Day's Range:6.09 - 6.20
    52wk Range:4.11 - 10.80
    Volume:24,252
    Avg Vol (3m):35,543
    Market Cap:127.45M
    P/E (ttm):N/A
    EPS (ttm):-3.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARGS

    Comparison

    Symbol% ChgMkt Cap
    ARGSUp 0.16%127.45M
    PFEDown 1.80%201.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):128.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.52
    Quarterly EPS Est (Sep-15) :-0.92
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Argos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases in North America. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback